Sarepta Therapeutics Inc (SRPT)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 235,239 | -535,977 | -703,488 | -418,780 | -554,128 |
| Total assets | US$ in thousands | 3,963,170 | 3,264,580 | 3,128,370 | 3,147,970 | 2,984,720 |
| ROA | 5.94% | -16.42% | -22.49% | -13.30% | -18.57% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $235,239K ÷ $3,963,170K
= 5.94%
The return on assets (ROA) for Sarepta Therapeutics Inc has shown significant fluctuations over the years based on the provided data. In 2020, the ROA was -18.57%, indicating that the company generated a negative return on its assets. However, in the subsequent years, there was some improvement as the ROA increased to -13.30% in 2021 but then dropped again to -22.49% in 2022.
The performance improved once more in 2023 with an ROA of -16.42%, showing a slight recovery. Notably, in 2024, there was a significant positive change as the ROA turned positive at 5.94%. This indicates that in 2024, Sarepta Therapeutics Inc generated a return on its assets, signaling a potential upturn in the company's profitability and efficiency in utilizing its assets to generate earnings.
Overall, the trend in ROA for Sarepta Therapeutics Inc has been volatile, with periods of negative returns followed by a notable positive change in 2024. This suggests the company may have faced challenges in asset utilization in the past but has since shown signs of improvement. These fluctuations in ROA should be closely monitored to assess the company's financial performance and efficiency in the future.
Peer comparison
Dec 31, 2024